Literature DB >> 15575833

New vehicle based on a microemulsion for topical ocular administration of dexamethasone.

Sílvia Ligório Fialho1, Armando da Silva-Cunha.   

Abstract

AIM: Eye drops are the most used dosage form by the ocular route, in spite of their low bioavailability. Due to their properties and numerous advantages, microemulsions are promising systems for topical ocular drug delivery. They can increase water solubility of the drug and enhance drug absorption into the eye. The present study describes the development and characterization of an oil-in-water microemulsion containing dexamethasone and the evaluation of its pharmacokinetics in rabbits after topical ocular application.
METHODS: The microemulsion was prepared by the titration technique. Its physico-chemical characteristics and stability were determined. The ocular irritation test and the pharmacokinetics of this system were studied in white rabbits.
RESULTS: The developed system showed an acceptable physico-chemical behaviour and presented good stability for 3 months. The ocular irritation test used suggested that the microemulsion did not provide significant alteration to eyelids, conjunctiva, cornea and iris. This formulation showed greater penetration of dexamethasone in the anterior segment of the eye and also release of the drug for a longer time when compared with a conventional preparation. The area under the curve obtained for the microemulsion system was more than twofold higher than that of the conventional preparation (P < 0.05).
CONCLUSIONS: The microemulsion-based dexamethasone eye drop is advantageous for ophthalmic use because it is well-tolerated in the eye and seemed to provide a higher degree of bioavailability. The developed system shows greater penetration in the eye, allowing the possibility of decreasing the number of applications of eye drops per day.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15575833     DOI: 10.1111/j.1442-9071.2004.00914.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  27 in total

1.  Nanoemulsion components screening and selection: a technical note.

Authors:  Adnan Azeem; Mohammad Rizwan; Farhan J Ahmad; Zeenat Iqbal; Roop K Khar; M Aqil; Sushama Talegaonkar
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

Review 2.  Nanocarriers of nanotechnology in retinal diseases.

Authors:  Ali M Al-Halafi
Journal:  Saudi J Ophthalmol       Date:  2014-03-05

3.  Preparation and evaluation of tretinoin microemulsion based on pseudo-ternary phase diagram.

Authors:  Eskandar Moghimipour; Anayatollah Salimi; Fatemeh Leis
Journal:  Adv Pharm Bull       Date:  2012-06-15

Review 4.  Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye.

Authors:  Yaru Wang; Changhong Wang
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

5.  Passive and oxymetazoline-enhanced delivery with a lens device: pharmacokinetics and efficacy studies with rabbits.

Authors:  David J Miller; S Kevin Li; Anthony L Tuitupou; Rajan P Kochambilli; Kongnara Papangkorn; Donald C Mix; William I Higuchi; John W Higuchi
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671

6.  Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy: Development, Characterization, and Pharmacodynamic Study.

Authors:  Parasuraman Mohan; Karthikeyan Kesavan
Journal:  AAPS PharmSciTech       Date:  2021-06-28       Impact factor: 3.246

7.  Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.

Authors:  Hussein O Ammar; H A Salama; M Ghorab; A A Mahmoud
Journal:  AAPS PharmSciTech       Date:  2009-06-18       Impact factor: 3.246

Review 8.  Principles of pharmacology in the eye.

Authors:  Sahar Awwad; Abeer H A Mohamed Ahmed; Garima Sharma; Jacob S Heng; Peng T Khaw; Steve Brocchini; Alastair Lockwood
Journal:  Br J Pharmacol       Date:  2017-10-10       Impact factor: 8.739

Review 9.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

Review 10.  Liposomes and nanotechnology in drug development: focus on ocular targets.

Authors:  Miki Honda; Tomohiro Asai; Naoto Oku; Yoshihiko Araki; Minoru Tanaka; Nobuyuki Ebihara
Journal:  Int J Nanomedicine       Date:  2013-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.